aluates Reports

$ 0.0

Automative

Global Natural Killer Cells Therapeutics Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-16C13496

Global Natural Killer Cells Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Natural Killer Cells Therapeutics Market Insights, Forecast to 2030

Code: QYRE-Auto-16C13496

Report

December 2024

Pages:105

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Affimed NV

Fate Therapeutics

Fortress Biotech

Glycostem Therapeutics

Innate Pharma

NantKwest Inc

Nkarta Therapeutics

NKT Therapeutics

ZIOPHARM Oncology

Celgene Corporation

Natural Killer Cells Therapeutics Market Size

The global Natural Killer Cells Therapeutics market is projected to grow from US$ 274.6 million in 2024 to US$ 398.5 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.4% during the forecast period.

Natural Killer Cells Therapeutics Market

Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.

Market Analysis and Insights: Global Natural Killer Cells Therapeutics Market

The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.

Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).

Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.

Report Covers:

This report presents an overview of global market for Natural Killer Cells Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Natural Killer Cells Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Natural Killer Cells Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Natural Killer Cells Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Natural Killer Cells Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Natural Killer Cells Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Natural Killer Cells Therapeutics Market Report

Report Metric	Details
Report Name	Natural Killer Cells Therapeutics Market
Accounted market size in 2024	US$ 274.6 million
Forecasted market size in 2030	US$ 398.5 million
CAGR	6.4
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	NK Cell Therapies NK Cell Directed Antibodies
Segment by Application	Research Centers & Institutes Hospitals Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Affimed, Celgene Corporation, Fate Therapeutics, Fortress Biotech, Glycostem Therapeutics, Innate Pharma, Nantkwest, Nkarta Therapeutics, NKT Therapeutics, Ziopharm Oncology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Natural Killer Cells Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Natural Killer Cells Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Natural Killer Cells Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Natural Killer Cells Therapeutics Market growing?

Ans: The Natural Killer Cells Therapeutics Market witnessing a CAGR of 6.4 during the forecast period 2025-2030.

What is the Natural Killer Cells Therapeutics Market size in 2030?

Ans: The Natural Killer Cells Therapeutics Market size in 2030 will be US$ 398.5 million.

What is the Natural Killer Cells Therapeutics Market share by region?

Ans: The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.

What is the market share of major companies in Natural Killer Cells Therapeutics Market?

Ans: The Top 6 players accounted for 96.66% of the global revenue market share in 2019.

Who are the main players in the Natural Killer Cells Therapeutics Market report?

Ans: The main players in the Natural Killer Cells Therapeutics Market are Affimed, Celgene Corporation, Fate Therapeutics, Fortress Biotech, Glycostem Therapeutics, Innate Pharma, Nantkwest, Nkarta Therapeutics, NKT Therapeutics, Ziopharm Oncology

What are the Application segmentation covered in the Natural Killer Cells Therapeutics Market report?

Ans: The Applications covered in the Natural Killer Cells Therapeutics Market report are Research Centers & Institutes, Hospitals, Others

What are the Type segmentation covered in the Natural Killer Cells Therapeutics Market report?

Ans: The Types covered in the Natural Killer Cells Therapeutics Market report are NK Cell Therapies, NK Cell Directed Antibodies

Recommended Reports

Cancer Therapeutics

Cell and Gene Therapy

Immunotherapy Strategies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 NK Cell Therapies

1.2.3 NK Cell Directed Antibodies

1.3 Market by Application

1.3.1 Global Natural Killer Cells Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Research Centers & Institutes

1.3.3 Hospitals

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Natural Killer Cells Therapeutics Market Perspective (2019-2030)

2.2 Global Natural Killer Cells Therapeutics Growth Trends by Region

2.2.1 Natural Killer Cells Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Natural Killer Cells Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Natural Killer Cells Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Natural Killer Cells Therapeutics Market Dynamics

2.3.1 Natural Killer Cells Therapeutics Industry Trends

2.3.2 Natural Killer Cells Therapeutics Market Drivers

2.3.3 Natural Killer Cells Therapeutics Market Challenges

2.3.4 Natural Killer Cells Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Natural Killer Cells Therapeutics by Players

3.1.1 Global Natural Killer Cells Therapeutics Revenue by Players (2019-2024)

3.1.2 Global Natural Killer Cells Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Natural Killer Cells Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Natural Killer Cells Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Natural Killer Cells Therapeutics Market Concentration Ratio

3.4.1 Global Natural Killer Cells Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Natural Killer Cells Therapeutics Revenue in 2023

3.5 Global Key Players of Natural Killer Cells Therapeutics Head office and Area Served

3.6 Global Key Players of Natural Killer Cells Therapeutics, Product and Application

3.7 Global Key Players of Natural Killer Cells Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Natural Killer Cells Therapeutics Breakdown Data by Type

4.1 Global Natural Killer Cells Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Natural Killer Cells Therapeutics Forecasted Market Size by Type (2025-2030)

5 Natural Killer Cells Therapeutics Breakdown Data by Application

5.1 Global Natural Killer Cells Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Natural Killer Cells Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Natural Killer Cells Therapeutics Market Size (2019-2030)

6.2 North America Natural Killer Cells Therapeutics Market Size by Type

6.2.1 North America Natural Killer Cells Therapeutics Market Size by Type (2019-2024)

6.2.2 North America Natural Killer Cells Therapeutics Market Size by Type (2025-2030)

6.2.3 North America Natural Killer Cells Therapeutics Market Share by Type (2019-2030)

6.3 North America Natural Killer Cells Therapeutics Market Size by Application

6.3.1 North America Natural Killer Cells Therapeutics Market Size by Application (2019-2024)

6.3.2 North America Natural Killer Cells Therapeutics Market Size by Application (2025-2030)

6.3.3 North America Natural Killer Cells Therapeutics Market Share by Application (2019-2030)

6.4 North America Natural Killer Cells Therapeutics Market Size by Country

6.4.1 North America Natural Killer Cells Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Natural Killer Cells Therapeutics Market Size by Country (2019-2024)

6.4.3 North America Natural Killer Cells Therapeutics Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Natural Killer Cells Therapeutics Market Size (2019-2030)

7.2 Europe Natural Killer Cells Therapeutics Market Size by Type

7.2.1 Europe Natural Killer Cells Therapeutics Market Size by Type (2019-2024)

7.2.2 Europe Natural Killer Cells Therapeutics Market Size by Type (2025-2030)

7.2.3 Europe Natural Killer Cells Therapeutics Market Share by Type (2019-2030)

7.3 Europe Natural Killer Cells Therapeutics Market Size by Application

7.3.1 Europe Natural Killer Cells Therapeutics Market Size by Application (2019-2024)

7.3.2 Europe Natural Killer Cells Therapeutics Market Size by Application (2025-2030)

7.3.3 Europe Natural Killer Cells Therapeutics Market Share by Application (2019-2030)

7.4 Europe Natural Killer Cells Therapeutics Market Size by Country

7.4.1 Europe Natural Killer Cells Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Natural Killer Cells Therapeutics Market Size by Country (2019-2024)

7.4.3 Europe Natural Killer Cells Therapeutics Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Natural Killer Cells Therapeutics Market Size (2019-2030)

8.2 China Natural Killer Cells Therapeutics Market Size by Type

8.2.1 China Natural Killer Cells Therapeutics Market Size by Type (2019-2024)

8.2.2 China Natural Killer Cells Therapeutics Market Size by Type (2025-2030)

8.2.3 China Natural Killer Cells Therapeutics Market Share by Type (2019-2030)

8.3 China Natural Killer Cells Therapeutics Market Size by Application

8.3.1 China Natural Killer Cells Therapeutics Market Size by Application (2019-2024)

8.3.2 China Natural Killer Cells Therapeutics Market Size by Application (2025-2030)

8.3.3 China Natural Killer Cells Therapeutics Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Natural Killer Cells Therapeutics Market Size (2019-2030)

9.2 Asia Natural Killer Cells Therapeutics Market Size by Type

9.2.1 Asia Natural Killer Cells Therapeutics Market Size by Type (2019-2024)

9.2.2 Asia Natural Killer Cells Therapeutics Market Size by Type (2025-2030)

9.2.3 Asia Natural Killer Cells Therapeutics Market Share by Type (2019-2030)

9.3 Asia Natural Killer Cells Therapeutics Market Size by Application

9.3.1 Asia Natural Killer Cells Therapeutics Market Size by Application (2019-2024)

9.3.2 Asia Natural Killer Cells Therapeutics Market Size by Application (2025-2030)

9.3.3 Asia Natural Killer Cells Therapeutics Market Share by Application (2019-2030)

9.4 Asia Natural Killer Cells Therapeutics Market Size by Region

9.4.1 Asia Natural Killer Cells Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Natural Killer Cells Therapeutics Market Size by Region (2019-2024)

9.4.3 Asia Natural Killer Cells Therapeutics Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Natural Killer Cells Therapeutics Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Natural Killer Cells Therapeutics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Natural Killer Cells Therapeutics Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Natural Killer Cells Therapeutics Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Natural Killer Cells Therapeutics Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Natural Killer Cells Therapeutics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Natural Killer Cells Therapeutics Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Natural Killer Cells Therapeutics Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Natural Killer Cells Therapeutics Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Natural Killer Cells Therapeutics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Natural Killer Cells Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Natural Killer Cells Therapeutics Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Natural Killer Cells Therapeutics Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Affimed

11.1.1 Affimed Company Details

11.1.2 Affimed Business Overview

11.1.3 Affimed Natural Killer Cells Therapeutics Introduction

11.1.4 Affimed Revenue in Natural Killer Cells Therapeutics Business (2019-2024)

11.1.5 Affimed Recent Developments

11.2 Celgene Corporation

11.2.1 Celgene Corporation Company Details

11.2.2 Celgene Corporation Business Overview

11.2.3 Celgene Corporation Natural Killer Cells Therapeutics Introduction

11.2.4 Celgene Corporation Revenue in Natural Killer Cells Therapeutics Business (2019-2024)

11.2.5 Celgene Corporation Recent Developments

11.3 Fate Therapeutics

11.3.1 Fate Therapeutics Company Details

11.3.2 Fate Therapeutics Business Overview

11.3.3 Fate Therapeutics Natural Killer Cells Therapeutics Introduction

11.3.4 Fate Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024)

11.3.5 Fate Therapeutics Recent Developments

11.4 Fortress Biotech

11.4.1 Fortress Biotech Company Details

11.4.2 Fortress Biotech Business Overview

11.4.3 Fortress Biotech Natural Killer Cells Therapeutics Introduction

11.4.4 Fortress Biotech Revenue in Natural Killer Cells Therapeutics Business (2019-2024)

11.4.5 Fortress Biotech Recent Developments

11.5 Glycostem Therapeutics

11.5.1 Glycostem Therapeutics Company Details

11.5.2 Glycostem Therapeutics Business Overview

11.5.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Introduction

11.5.4 Glycostem Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024)

11.5.5 Glycostem Therapeutics Recent Developments

11.6 Innate Pharma

11.6.1 Innate Pharma Company Details

11.6.2 Innate Pharma Business Overview

11.6.3 Innate Pharma Natural Killer Cells Therapeutics Introduction

11.6.4 Innate Pharma Revenue in Natural Killer Cells Therapeutics Business (2019-2024)

11.6.5 Innate Pharma Recent Developments

11.7 Nantkwest

11.7.1 Nantkwest Company Details

11.7.2 Nantkwest Business Overview

11.7.3 Nantkwest Natural Killer Cells Therapeutics Introduction

11.7.4 Nantkwest Revenue in Natural Killer Cells Therapeutics Business (2019-2024)

11.7.5 Nantkwest Recent Developments

11.8 Nkarta Therapeutics

11.8.1 Nkarta Therapeutics Company Details

11.8.2 Nkarta Therapeutics Business Overview

11.8.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Introduction

11.8.4 Nkarta Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024)

11.8.5 Nkarta Therapeutics Recent Developments

11.9 NKT Therapeutics

11.9.1 NKT Therapeutics Company Details

11.9.2 NKT Therapeutics Business Overview

11.9.3 NKT Therapeutics Natural Killer Cells Therapeutics Introduction

11.9.4 NKT Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024)

11.9.5 NKT Therapeutics Recent Developments

11.10 Ziopharm Oncology

11.10.1 Ziopharm Oncology Company Details

11.10.2 Ziopharm Oncology Business Overview

11.10.3 Ziopharm Oncology Natural Killer Cells Therapeutics Introduction

11.10.4 Ziopharm Oncology Revenue in Natural Killer Cells Therapeutics Business (2019-2024)

11.10.5 Ziopharm Oncology Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Affimed NV

Fate Therapeutics

Fortress Biotech

Glycostem Therapeutics

Innate Pharma

NantKwest Inc

Nkarta Therapeutics

NKT Therapeutics

ZIOPHARM Oncology

Celgene Corporation

List of Tables

Table 1. Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of NK Cell Therapies

Table 3. Key Players of NK Cell Directed Antibodies

Table 4. Global Natural Killer Cells Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Natural Killer Cells Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Natural Killer Cells Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Natural Killer Cells Therapeutics Market Share by Region (2019-2024)

Table 8. Global Natural Killer Cells Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Natural Killer Cells Therapeutics Market Share by Region (2025-2030)

Table 10. Natural Killer Cells Therapeutics Market Trends

Table 11. Natural Killer Cells Therapeutics Market Drivers

Table 12. Natural Killer Cells Therapeutics Market Challenges

Table 13. Natural Killer Cells Therapeutics Market Restraints

Table 14. Global Natural Killer Cells Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Natural Killer Cells Therapeutics Revenue Share by Players (2019-2024)

Table 16. Global Top Natural Killer Cells Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cells Therapeutics as of 2023)

Table 17. Global Natural Killer Cells Therapeutics Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Natural Killer Cells Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Natural Killer Cells Therapeutics, Headquarters and Area Served

Table 20. Global Key Players of Natural Killer Cells Therapeutics, Product and Application

Table 21. Global Key Players of Natural Killer Cells Therapeutics, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Natural Killer Cells Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Natural Killer Cells Therapeutics Revenue Market Share by Type (2019-2024)

Table 25. Global Natural Killer Cells Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Natural Killer Cells Therapeutics Revenue Market Share by Type (2025-2030)

Table 27. Global Natural Killer Cells Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Natural Killer Cells Therapeutics Revenue Share by Application (2019-2024)

Table 29. Global Natural Killer Cells Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Natural Killer Cells Therapeutics Revenue Share by Application (2025-2030)

Table 31. North America Natural Killer Cells Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Natural Killer Cells Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Natural Killer Cells Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Natural Killer Cells Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Natural Killer Cells Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Natural Killer Cells Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Natural Killer Cells Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Natural Killer Cells Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Natural Killer Cells Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Natural Killer Cells Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Natural Killer Cells Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Natural Killer Cells Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Natural Killer Cells Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Natural Killer Cells Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Natural Killer Cells Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Natural Killer Cells Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Natural Killer Cells Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Natural Killer Cells Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Natural Killer Cells Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Natural Killer Cells Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Natural Killer Cells Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Natural Killer Cells Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Natural Killer Cells Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Natural Killer Cells Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Natural Killer Cells Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Natural Killer Cells Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Natural Killer Cells Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Natural Killer Cells Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Natural Killer Cells Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Natural Killer Cells Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Natural Killer Cells Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Natural Killer Cells Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 63. Affimed Company Details

Table 64. Affimed Business Overview

Table 65. Affimed Natural Killer Cells Therapeutics Product

Table 66. Affimed Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)

Table 67. Affimed Recent Developments

Table 68. Celgene Corporation Company Details

Table 69. Celgene Corporation Business Overview

Table 70. Celgene Corporation Natural Killer Cells Therapeutics Product

Table 71. Celgene Corporation Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)

Table 72. Celgene Corporation Recent Developments

Table 73. Fate Therapeutics Company Details

Table 74. Fate Therapeutics Business Overview

Table 75. Fate Therapeutics Natural Killer Cells Therapeutics Product

Table 76. Fate Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)

Table 77. Fate Therapeutics Recent Developments

Table 78. Fortress Biotech Company Details

Table 79. Fortress Biotech Business Overview

Table 80. Fortress Biotech Natural Killer Cells Therapeutics Product

Table 81. Fortress Biotech Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)

Table 82. Fortress Biotech Recent Developments

Table 83. Glycostem Therapeutics Company Details

Table 84. Glycostem Therapeutics Business Overview

Table 85. Glycostem Therapeutics Natural Killer Cells Therapeutics Product

Table 86. Glycostem Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)

Table 87. Glycostem Therapeutics Recent Developments

Table 88. Innate Pharma Company Details

Table 89. Innate Pharma Business Overview

Table 90. Innate Pharma Natural Killer Cells Therapeutics Product

Table 91. Innate Pharma Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)

Table 92. Innate Pharma Recent Developments

Table 93. Nantkwest Company Details

Table 94. Nantkwest Business Overview

Table 95. Nantkwest Natural Killer Cells Therapeutics Product

Table 96. Nantkwest Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)

Table 97. Nantkwest Recent Developments

Table 98. Nkarta Therapeutics Company Details

Table 99. Nkarta Therapeutics Business Overview

Table 100. Nkarta Therapeutics Natural Killer Cells Therapeutics Product

Table 101. Nkarta Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)

Table 102. Nkarta Therapeutics Recent Developments

Table 103. NKT Therapeutics Company Details

Table 104. NKT Therapeutics Business Overview

Table 105. NKT Therapeutics Natural Killer Cells Therapeutics Product

Table 106. NKT Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)

Table 107. NKT Therapeutics Recent Developments

Table 108. Ziopharm Oncology Company Details

Table 109. Ziopharm Oncology Business Overview

Table 110. Ziopharm Oncology Natural Killer Cells Therapeutics Product

Table 111. Ziopharm Oncology Revenue in Natural Killer Cells Therapeutics Business (2019-2024) & (US$ Million)

Table 112. Ziopharm Oncology Recent Developments

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Natural Killer Cells Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. NK Cell Therapies Features

Figure 4. NK Cell Directed Antibodies Features

Figure 5. Global Natural Killer Cells Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Natural Killer Cells Therapeutics Market Share by Application: 2023 VS 2030

Figure 7. Research Centers & Institutes Case Studies

Figure 8. Hospitals Case Studies

Figure 9. Others Case Studies

Figure 10. Natural Killer Cells Therapeutics Report Years Considered

Figure 11. Global Natural Killer Cells Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Natural Killer Cells Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Natural Killer Cells Therapeutics Market Share by Region: 2023 VS 2030

Figure 14. Global Natural Killer Cells Therapeutics Market Share by Players in 2023

Figure 15. Global Top Natural Killer Cells Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cells Therapeutics as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Natural Killer Cells Therapeutics Revenue in 2023

Figure 17. North America Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Natural Killer Cells Therapeutics Market Share by Type (2019-2030)

Figure 19. North America Natural Killer Cells Therapeutics Market Share by Application (2019-2030)

Figure 20. North America Natural Killer Cells Therapeutics Market Share by Country (2019-2030)

Figure 21. United States Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Natural Killer Cells Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 24. Europe Natural Killer Cells Therapeutics Market Share by Type (2019-2030)

Figure 25. Europe Natural Killer Cells Therapeutics Market Share by Application (2019-2030)

Figure 26. Europe Natural Killer Cells Therapeutics Market Share by Country (2019-2030)

Figure 27. Germany Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China Natural Killer Cells Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 34. China Natural Killer Cells Therapeutics Market Share by Type (2019-2030)

Figure 35. China Natural Killer Cells Therapeutics Market Share by Application (2019-2030)

Figure 36. Asia Natural Killer Cells Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 37. Asia Natural Killer Cells Therapeutics Market Share by Type (2019-2030)

Figure 38. Asia Natural Killer Cells Therapeutics Market Share by Application (2019-2030)

Figure 39. Asia Natural Killer Cells Therapeutics Market Share by Region (2019-2030)

Figure 40. Japan Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Taiwan Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Natural Killer Cells Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Natural Killer Cells Therapeutics Market Share by Type (2019-2030)

Figure 48. Middle East, Africa, and Latin America Natural Killer Cells Therapeutics Market Share by Application (2019-2030)

Figure 49. Middle East, Africa, and Latin America Natural Killer Cells Therapeutics Market Share by Country (2019-2030)

Figure 50. Brazil Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Mexico Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Turkey Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Israel Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GCC Countries Natural Killer Cells Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Affimed Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)

Figure 57. Celgene Corporation Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)

Figure 58. Fate Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)

Figure 59. Fortress Biotech Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)

Figure 60. Glycostem Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)

Figure 61. Innate Pharma Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)

Figure 62. Nantkwest Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)

Figure 63. Nkarta Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)

Figure 64. NKT Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)

Figure 65. Ziopharm Oncology Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2019-2024)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global NK Cell Therapy Market Insights Forecast to 2030

Natural Killer NK Cell Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Natural Killer Cell Therapeutics Market Research Report 2024

Global Cell Therapy Market Insights Forecast to 2030

Global Cancer Biotherapy Market Insights Forecast to 2030

Global Adoptive Cell Therapy Market Insights Forecast to 2030

Immune Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Immuno oncology Therapy Market Insights Forecast to 2030

Global Stem Cell Therapy Market Insights Forecast to 2030

Global Stem Cell Treatments Market Insights Forecast to 2030

Global Cytotherapy Market Insights Forecast to 2030

Global Immunocell Therapy Market Insights Forecast to 2030

Global Immuno Cell Therapy Market Research Report 2024

Global Tumor Immune Cell Therapy Market Research Report 2024

Global Cell Transplantatio Therapy Market Insights Forecast to 2030

Global Autologous Cell Therapy Market Insights Forecast to 2030

Global Gene Therapies for Tumor Treatment Market Insights Forecast to 2030

Global Cellular Therapy CT Market Insights Forecast to 2030

Global Cancer Immunotherapy Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions